About Frankly Peptides
A body doing something measurable and a person doing better can be a long way apart.
Why Frankly
The word frankly gives me permission to admit an unflattering result without performing cynicism. A peptide can have fascinating biology and a weak treatment case. A disappointing trial can be more useful than a much more exciting explanation of how a molecule ought to work.
Frankly Peptides is a collection of essays about published research on BPC-157, MOTS-c, KPV and thymosin alpha-1. I like the bodily consequences in these experiments: a tendon pulled until its strength can be measured, a mouse moving on a treadmill, a peptide protected inside a gel. Those details make an experiment easier to take seriously and harder to stretch into a universal promise.
The site provides no medical advice. It cannot assess an illness or decide whether a treatment is appropriate. Frankly Peptides has no treatment service or shop; the contact address is for research corrections.
MOTS-c patient measurements
The MOTS-c study in people receiving dialysis makes that uncomfortable space unusually concrete. It involved human illness, blood measurements and later outcomes, while giving nobody MOTS-c as treatment. Calling that human evidence is fair. Imagining an established treatment benefit would go beyond what happened.
I respect those rat tendon measurements. The rat tendon experiment measured recovery in several ways, including strength and function. Those findings earn scientific interest. The missing human healing trials deserve a sentence of their own, without erasing the rats’ results.
Thymosin alpha-1 sepsis result
The large thymosin alpha-1 sepsis trial asks the hard question directly and supplies an unwelcome answer: no statistically significant mortality benefit in that setting. Thymosin alpha-1’s immune effects still interest me. Its sepsis mortality result has answered one clinical question; other proposed uses need their own tests.
Factual corrections belong at the contact address. The reading list gathers the studies discussed here. A convincing new result could move this argument; enthusiasm alone cannot do that work.